NLRP3 inflammasome activation in dialyzed chronic kidney disease patients

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Granata, Simona ^a   Masola, Valentina ^a   Zoratti, Elisa ^b   Scupoli, Maria Teresa ^b   Baruzzi, Anna ^b   Messa, Michele ^a   Sallustio, Fabio ^c   Gesualdo, Loreto ^c   Lupo, Antonio ^a   Zaza, Gianluigi ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; APOPTOSIS ASSOCIATED SPECK LIKE PROTEIN CONTAINING A CARD; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPOPOLYSACCHARIDE; MESSENGER RNA; PURINERGIC P2X7 RECEPTOR; REACTIVE OXYGEN METABOLITE; THIOREDOXIN INTERACTING PROTEIN; UNCLASSIFIED DRUG; AMINE OXIDE; AUTACOID; CARRIER PROTEIN; CYTOKINE; NLRP3 PROTEIN, HUMAN; TEMPO;

ADULT; ARTICLE; CARD8 GENE; CASP1 GENE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE; GENE EXPRESSION; HEMODIALYSIS; HUMAN; HUMAN CELL; MALE; MICROARRAY ANALYSIS; MITOCHONDRION; NAIP5 GENE; NLRP3 GENE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; TXNIP GENE; UPREGULATION; WESTERN BLOTTING; CASE CONTROL STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PROTEIN TRANSPORT; RENAL INSUFFICIENCY, CHRONIC;

VASCONCELLEA CANDICANS;

ADULT; CARRIER PROTEINS; CASE-CONTROL STUDIES; CASPASE 1; CYCLIC N-OXIDES; CYTOKINES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFLAMMASOMES; INFLAMMATION MEDIATORS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MITOCHONDRIA; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; PROTEIN TRANSPORT; REACTIVE OXYGEN SPECIES; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84925797522     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122272     Document Type: Article

References (64)

1. Coresh J, Astor BC, Greene T, Eknoyan G., Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003; 41:1-12. PMID: 12500213
2. Hamer RA, El Nahas AM. The burden of chronic kidney disease. BMJ 2006; 332:563-564. PMID: 16528062
3. Grassmann A, Gioberge S, Moeller S., Brown G. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant. 2005; 20:2587-2593. PMID: 16204281
4. US Renal Data System, USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2013
5. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007; 116:85-97. PMID: 17606856
6. Patel UD, Young EW, Ojo A.O., Hayward RA. CKD progression and mortality among older patients with diabetes. Am J Kidney Dis. 2005; 46:406-414. PMID: 16129201
7. Slee AD. Exploring metabolic dysfunction in chronic kidney disease. NutrMetab. (Lond) 2012; 9:36. doi: 10.1186/1743-7075-9-36 PMID: 22537670
8. Kalantar-Zadeh K, Ikizler TA, Block G, Avram M.M., Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: Causes and consequence. Am J Kidney Dis. 2003; 42:864-881. PMID: 14582032
9. Kato S, Chmielewski M, Honda H., Pecoits-Filho R, Matsuo S, Yuzawa Y., et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol. 2008; 3:1526-1533. doi: 10.2215/CJN. 00950208 PMID: 18701615
10. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 392 (Suppl 1):S1-266. PMID: 11904577
11. Libetta C, Sepe V, Esposito P., Galli F, Dal Canton A. Oxidative stress and inflammation: Implications in uremia and hemodialysis. Clin Biochem. 2011; 44:1189-1198. doi: 10.1016/j.clinbiochem.2011.06.988 PMID: 21777574
12. Lazarus JM, Owen WF. Role of bioincompatibility in dialysis morbidity and mortality. Am J Kidney Dis. 1994; 24:1019-1032. PMID: 7985663
13. Ward RA, McLeish KR. Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency. J Am Soc Nephrol. 1995; 5:1697-1702. PMID: 7780059
14. Akahoshi T, Kobayashi N, Hosaka S., Sekiyama N, Wada C, Kondo H. In vivo induction of monocyte chemotactic and activating factor in patients with chronic renal failure. Nephrol Dial Transplant. 1995; 10:2244-2249. PMID: 8808219
15. Zaza G, Pontrelli P, Pertosa G., Granata S, Rossini M, Porreca S., et al. Dialysis-related systemic micro-inflammation is associated with specific genomic patterns. Nephrol Dial Transplant. 2008; 23:1673-1681. PMID: 18048420
16. Lonnemann G, van der Meer JW, Cannon JG, Dinarello CA, Koch KM, Granolleras C, et al. Induction of tumor necrosis factor during extracorporeal blood purification. N Engl J Med. 1987; 317:963-964. PMID: 3627217
17. Nakanishi I, Moutabarrik A, Okada N., Kitamura E, Hayashi A, Syouji T., et al. Interleukin-8 in chronic renal failure and dialysis patients. Nephrol Dial Transplant. 1994; 9:1435-1442. PMID: 7816257
18. Cheung AK, Parker CJ, Wilcox L.A., Janatova J. Activation of complement by hemodialysis membranes: Polyacrylonitrile binds more C3athan cuprophan. Kidney Int 1990; 37:1055-1059. PMID: 2342244
19. Himmelfarb J, Stenvinkel P, Ikizler T.A., Hakim RM. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002; 62:1524-1538. PMID: 12371953
20. Pertosa G, Simone S, Ciccone M., Porreca S, Zaza G, Dalfino G., et al. Serum fetuin a in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis? Am J Kidney Dis. 2009; 53:467-474. doi: 10.1053/j.ajkd.2008.10.046 PMID: 19167798
21. Kotur-Stevuljevic J, Simic-Ogrizovic S, Dopsaj V., Stefanovic A, Vujovic A, Ivanic-Corlomanovic T, et al. A hazardous link between malnutrition, inflammation and oxidative stress in renal patients. Clin Biochem. 2012; 45:1202-1205. doi: 10.1016/j.clinbiochem.2012.04.021 PMID: 22580395
22. Handelman GJ, Walter MF, Adhikarla R, Gross J., Dallal GE, Levin NW, et al. Elevated plasma F2-iso-prostanes in patients on long-term hemodialysis. Kidney Int. 2001; 59:1960-1966. PMID: 11318969
23. Mezzano D, Pais EO, Aranda E, Panes O., Downey P, Ortiz M, et al. Inflammation, nothyperhomocys-teinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. Kidney Int. 2001; 60:1844-1850. PMID: 11703602
24. Chanard J, Lavaud S, Randoux C., Rieu P. New insights in dialysis membrane biocompatibility: relevance of adsorption properties and heparin binding. Nephrol Dial Transplant. 2003; 18:252-257. PMID: 12543877
25. Tomo T, Shinoda T. Biocompatibility of dialysis fluid for online HDF. Contrib Nephrol. 2011; 168:89-98. doi: 10.1159/000321747 PMID: 20938128
26. Hajnóczky G, Csordás G, Das S., Garcia-Perez C, Saotome M, Sinha Roy S, et al. Mitochondrial calcium signalling and cell death: approaches for assessing the role of mitochondrial Ca2+ uptake in apo-ptosis. Cell Calcium 2006; 40:553-560. PMID: 17074387
27. Ajioka RS, Phillips JD, Kushner JP. Biosynthesis of heme in mammals. Biochim Biophys Acta 2006; 1763:723-736. PMID: 16839620
28. Rossier MF. T channels and steroid biosynthesis: in search of a link with mitochondria. Cell Calcium 2006; 40:155-164. PMID: 16759697
29. Green DR. Apoptotic pathways: the roads to ruin. Cell 1998; 94:695-698. PMID: 9753316
30. West AP, Shadel GS, Ghosh S. Mitochondria in innate immune responses. Nat Rev Immunol. 2011; 11:389-402. doi: 10.1038/nri2975 PMID: 21597473
31. Arnoult D, Soares F, Tattoli I., Girardin SE. Mitochondria in innate immunity. EMBORep. 2011; 12:901-910. doi: 10.1038/embor.2011.157 PMID: 21799518
32. Fritz JH, Girardin SE. How Toll-like receptors and Nod-like receptors contribute to innate immunity in mammals. J Endotoxin Res. 2005; 11:390-394. PMID: 16303096
33. Ting JP, Lovering RC, Alnemri E.S., Bertin J., Boss JM, Davis BK, et al. The NLR gene family: a standard nomenclature. Immunity 2008; 28:285-287. doi: 10.1016/j.immuni.2008.02.005 PMID: 18341998
34. Schroder K, Tschopp J. The inflammasomes. Cell 2010; 140:821-832. doi: 10.1016/j.cell.2010.01.040 PMID: 20303873
35. Geddes K, Magalhäes JG, Girardin SE. Unleashing the therapeutic potential of NOD-like receptors. Nat Rev Drug Discov. 2009; 8:465-479. doi: 10.1038/nrd2783 PMID: 19483708
36. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β Mol. Cell 2002; 10:417-426.
37. Dinarello CA. Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme. Ann N Y Acad Sci. 1998; 856:1-11. PMID: 9917859
38. Muñoz-Planillo R., Franchi L, Miller LS, Núñez G. A critical role for hemolysins and bacterial lipoproteins in Staphylococcus aureus-induced activation of the Nlrp3 inflammasome. J Immunol. 2009; 183:3942-3948. doi: 10.4049/jimmunol.0900729 PMID: 19717510
39. Mariathasan S, Weiss DS, Newton K, McBride J., O'Rourke K, Roose-Girma M, et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006; 440:228-232. PMID: 16407890
40. Dostert C, Pétrilli V, Van Bruggen R, Steele C, Mossman B.T., Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008; 320:674-677. doi: 10. 1126/science.1156995 PMID: 18403674
41. Latz E. The inflammasomes: mechanisms of activation and function. CurrOpin Immunol. 2010; 22:28-33. doi: 10.1016/j.coi.2009.12.004 PMID: 20060699
42. Anders HJ, Muruve DA. The inflammasomes in kidney disease. J Am Soc Nephrol. 2011; 22:1007-1018. doi: 10.1681/ASN.2010080798 PMID: 21566058
43. Anders HJ, Banas B, Schlöndorff D. Signaling danger: toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol. 2004; 15:854-867. PMID: 15034087
44. Di Virgilio F. Liaisons dangereuses: P2X(7)andthe inflammasome. Trends Pharmacol Sci. 2007; 28:465-472. PMID: 17692395
45. Granata S, Zaza G, Simone S., Villani G, Latorre D, Pontrelli P., et al. Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease. BMC Genomics 2009; 10:388. doi: 10.1186/ 1471-2164-10-388 PMID: 19698090
46. Veal EA, Day AM, Morgan BA. Hydrogen peroxide sensing and signaling. Mol Cell. 2007; 26:1-14. PMID: 17434122
47. Vilaysane A, Chun J, Seamone M.E., Wang W., Chin R, Hirota S, et al. The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J Am Soc Nephrol. 2010; 21:1732-1744. doi: 10. 1681/ASN.2010020143 PMID: 20688930
48. Vesey DA, Cheung C, Cuttle L., Endre Z, Gobe G, Johnson DW. Interleukin-1 beta stimulates human renal fibroblast proliferation and matrix protein production by means of a transforming growth factor-beta-dependent mechanism. J Lab Clin Med. 2002; 140:342-350. PMID: 12434136
49. Liang D, Liu HF, Yao C.W., Liu HY, Huang-Fu CM, Chen XW, et al. Effects of interleukin 18 on injury and activation of human proximal tubular epithelial cells. Nephrology (Carlton). 2007; 12:53-61. PMID: 17295661
50. Muruve DA, Pétrilli V, Zaiss A.K., White LR, Clark SA, Ross PJ, et al. The inflammasome recognizes cy-tosolic microbial and host DNA and triggers an innate immune response. Nature 2008; 452:103-107. doi: 10.1038/nature06664 PMID: 18288107
51. Zhou R, Tardivel A, Thorens B., Choi I, Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol. 2010; 11:136-140. doi: 10.1038/ni.1831 PMID: 20023662
52. Martinon F, Pétrilli V, Mayor A., Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006; 440:237-241. PMID: 16407889
53. Yamasaki K, Muto J, Taylor K.R., Cogen AL, Audish D, Bertin J, et al. NLRP3/cryopyrin is necessary for interleukin-1beta (IL-1beta) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury. J Biol Chem. 2009; 284:12762-12771. doi: 10.1074/jbc.M806084200 PMID: 19258328
54. Babelova A, Moreth K, Tsalastra-Greul W, Zeng-Brouwers J, Eickelberg O, Young M.F., et al. Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J Biol Chem. 2009; 284:24035-24048. doi: 10.1074/jbc.M109.014266 PMID: 19605353
55. Zhuang Y, Ding G, Zhao M., Bai M, Yang L, Ni J., et al. NLRP3 inflammasome mediates albumin-induced renal tubular injury through impaired mitochondrial function. J Biol Chem. 2014; 289:25101-25111. doi: 10.1074/jbc.M114.578260 PMID: 25059664
56. Shahzad K, Bock F, Dong W., Wang H, Kopf S, Kohli S., et al. Nlrp3-inflammasome activation in non-my-eloid-derived cells aggravates diabetic nephropathy. Kidney Int. 2015; 87:74-84. doi: 10.1038/ki.2014. 271 PMID: 25075770
57. Chan SI and Li PM. Cytochrome c oxidase: understanding nature's design of a proton pump. Biochemistry 1990; 29:1-12. PMID: 2157476
58. Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011; 469:221-225. doi: 10.1038/nature09663 PMID: 21124315
59. Nakahira K, Haspel JA, Rathinam V.A., Lee SJ, Dolinay T, Lam HC, et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol. 2011; 12:222-230. doi: 10.1038/ni.1980 PMID: 21151103
60. van der Burgh R, Nijhuis L, Pervolaraki K, Compeer EB, Jongeneel LH, van Gijn M, et al. Defects in mitochondrial clearance predispose human monocytes to interleukin-1 β hypersecretion. J Biol Chem. 2014; 289:5000-5012. doi: 10.1074/jbc.M113.536920 PMID: 24356959
61. Schreiber A, Luft FC, Kettritz R. Phagocyte NADPH Oxidase Restrains the Inflammasome in ANCA-Induced GN. J Am Soc Nephrol. 2015; 26:411-424. doi: 10.1681/ASN.2013111177 PMID: 25012177
62. Razmara M, Srinivasula SM, Wang L, Poyet J.L., Geddes BJ, DiStefano PS, et al. CARD-8 protein, a new CARD family member that regulates caspase-1 activation and apoptosis. J Biol Chem. 2002; 277:13952-13958. PMID: 11821383
63. Ito S, Hara Y, Kubota T. CARD8 is a negative regulator for NLRP3 inflammasome, but mutant NLRP3 in cryopyrin-associated periodic syndromes escapes the restriction. Arthritis ResTher. 2014; 16(1): R52. doi: 10.1186/ar4483 PMID: 24517500
64. Wang M, Crager M, Pugazhenthi S. Modulation of apoptosis pathways by oxidative stress and autophagy in β cells. Exp Diabetes Res. 2012; 2012:647914. doi: 10.1155/2012/647914 PMID: 22474427